ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2025

Feb 27, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK: 0001281895
Period of Report: 2024-05-17

Reporting Person: Schwartz Jonathan David (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-05-17	Common Stock	S	2754	$23.35	Disposed	169659	Direct
2024-08-16	Common Stock	S	2710	$18.5	Disposed	166949	Direct
2024-11-21	Common Stock	S	3097	$13.05	Disposed	163852	Direct
2025-02-25	Common Stock	S	6532	$10.58	Disposed	237638	Direct

Footnotes

F1: Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.

F2: The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.

F3: Inclusive of the acquisition of 80,318 RSUs that convert to common stock on a one-for-one basis, as reported on the Reporting Person's Form 4 filed on 02/13/2025.